After years in which medical headlines went to tranquilizing drugs, it looks as though 1957's drug of the year is an anti-tranquilizer. Its name: iproniazid. Dropped like a hot potato after 1951 trials against tuberculosis because of admittedly unpleasant and possibly serious side effects, iproniazid was shunned until about a year ago, when psychiatrists decided that it might be useful against deep, unshakable states of depression. The first few researchers got encouraging results (TIME, April 15). A fortnight ago, at a Manhattan conference sponsored by Hoffmann-La Roche, Inc., which markets the prescription drug, more psychiatrists affirmed their faith in iproniazid, and...
Medicine: Drug of the Year?
Subscriber content preview.
or
Log-In
To continue reading:
or
Log-In